Viewing Study NCT02766634


Ignite Creation Date: 2025-12-25 @ 2:26 AM
Ignite Modification Date: 2026-01-07 @ 11:45 AM
Study NCT ID: NCT02766634
Status: COMPLETED
Last Update Posted: 2016-07-21
First Post: 2016-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module